AI assistant
SABIEN TECHNOLOGY GROUP PLC — Earnings Release 2019
Feb 4, 2019
7894_bfr_2019-02-04_1f8d00a4-a29b-42d7-9d87-3c86e6f67632.html
Earnings Release
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 0220P
Sabien Technology Group PLC
04 February 2019
For immediate release
4 February 2019
Sabien Technology Group plc
("Sabien" or "the Company")
Corporate Update - Orders received
Sabien Technology Group plc (AIM: SNT), the manufacturer and supplier of M2G, a boiler energy efficiency technology, is pleased to announce it has received sales orders totalling £146,187 for the month of January 2019. This brings total orders for the financial year ending June 2019 to £278,332. In comparison, sales orders for the six-month period ended 31 December 2018 totalled £132,145. Sales orders in the month of January alone therefore represent an increase of approximately 10% compared to the previous six months. All sales revenue will be realised in this financial year.
Orders have been received from UK customers, including local councils, and from Sabien's overseas distribution network in the US.
The company announces also that it will be publishing its interim results for the six-months ended 31 December 2018, including an update on outlook for the rest of the year, during the week commencing 11th of February 2019.
For further information:
| Sabien Technology Group plc Alan O'Brien |
+44(0)20 7993 3700 |
| Beaumont Cornish Limited (Nominated Advisor) Michael Cornish and Roland Cornish www.beaumontcornish.com |
+44(0)20 7628 3396 |
| Peterhouse Capital Limited (Broker) Martin Lampshire and Fungai Ndoro |
+44(0)20 7469 0930 |
ENDS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
UPDSSAFILFUSEFE